Giant prolactinoma, a case report and review of the literature

Doua K. Al Homyani1, Reem A. Al Khalifah1, Ikhlass S. Al Tuwaijri2, Rushaid N. Al Jurayyan3, Nasir A. Al Jurayyan4
1Endocrine Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia
2Neurosurgery Division, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia
3Department of Radiology and Medical Imaging, College of Medicine, King Saud University, Riyadh, Saudi Arabia
4Endocrine Division, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Tài liệu tham khảo

Colao, 1998, Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up, J Clin Endocrinol Metab, 83, 2777, 10.1210/jcem.83.8.5001 Fideleff, 2009, Prolactinoma in children and adolescents, Horm Res, 72, 197, 10.1159/000236081 Minniti, 2002, Giant prolactinomas presenting as skull base tumors, Surg Neurol, 57, 94, 10.1016/S0090-3019(01)00697-8 Shrivastava, 2002, Giant prolactinomas: clinical management and long-term follow up, J Neurosurg, 97, 299, 10.3171/jns.2002.97.2.0299 Heras, 2008, Nephrotic-range proteinuria in a patient with a giant prolactinoma, Am J Kidney Dis, 51, 1025, 10.1053/j.ajkd.2008.02.310 Iglesias, 2013, Macroprolactinoma: a diagnostic and therapeutic update, QJM An Int J Med, 106, 495, 10.1093/qjmed/hcs240 Shimon, 2007, Effectiveness of long-term cabergoline treatment for giant prolactinoma: study of 12 men, Eur J Endocrinol, 156, 225, 10.1530/EJE-06-0646 DAVIS, 1990, Giant invasive prolactinoma: a case report and review of nine further cases, QJM An Int J Med, 74, 227 Grebe, 1992, Treatment of extensively invasive (giant) prolactinomas with bromocriptine, N Z Med J, 105, 129 Verhelst, 1999, Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients, J Clin Endocrinol Metab, 84, 2518, 10.1210/jcem.84.7.5810 Tu, 2016, Surgical versus non-surgical treatment for pituitary apoplexy: a systematic review and meta-analysis, J Neurol Sci, 370, 258, 10.1016/j.jns.2016.09.047 Xu, 2008, Transsphenoidal microsurgical results of non-invasive prolactinomas, Zhonghua Wai Ke Za Zhi, 46, 293 D'Ambrosio, 2009, Simultaneous above and below approach to giant pituitary adenomas: surgical strategies and long-term follow-up, Pituitary, 12, 217, 10.1007/s11102-009-0171-5 Sunil, 2013, Invasive giant prolactinoma presenting as a nasal polyp, J Pediatr, 162, 10.1016/j.jpeds.2012.08.029 Cackett, 2012, Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy, Future Oncol, 8, 1621, 10.2217/fon.12.149 Furtado, 2010, Giant, solid, invasive prolactinoma in a prepubescent boy with gynecomastia, Pediatr Neurol, 42, 72, 10.1016/j.pediatrneurol.2009.08.005 Dinc, 2008, Cystic giant prolactinoma in childhood, J Clin Neurosci Off J Neurosurg Soc Australas, 15, 76 Semple, 2007, Giant prolactinomas in adolescence: an uncommon cause of blindness, Childs Nerv Syst, 23, 213, 10.1007/s00381-006-0177-5 Fraioli, 2010, Multidisciplinary treatment of giant invasive prolactinomas in paediatric age: long-term follow-up in two children, Childs Nerv Syst, 26, 1233, 10.1007/s00381-010-1129-7 Gan, 2015, Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1, Int J Pediatr Endocrinol, 2015, 15, 10.1186/s13633-015-0011-5 Christoforidis, 2013, Impressive shrinkage of a giant prolactinoma treated with cabergoline in a prepubescent girl. What now?, Neuroendocrinol Lett, 34, 275 Sano, 2009, Cabergoline effectively induced remission of prolactinoma in a 9-year-old Japanese boy, Clin Pediatr Endocrinol Case Rep Clin Investig Off J Jpn Soc Pediatr Endocrinol, 18, 65 Krassas, 1999, Giant prolactinoma presented as unilateral exophthalmos in a prepubertal boy: response to cabergoline, Horm Res, 52, 45 Chaurasia, 2011, Epistaxis as first clinical presentation in a child with giant prolactinoma: case report and review of literature, J Pediatr Neurosci, 6, 134 Colao, 2004, Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis, J Clin Endocrinol Metab, 89, 1704, 10.1210/jc.2003-030979 Ono, 2008, Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients, J Clin Endocrinol Metab, 93, 4721, 10.1210/jc.2007-2758 Horvath, 2004, Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists, Mov Disord, 19, 656, 10.1002/mds.20201 Krassas, 1999, Giant prolactinoma presented as unilateral exophthalmos in a prepubertal boy: response to cabergoline, Horm Res, 52, 45